New Immunotherapy Advances Presented at the AACR Annual Meeting 2015
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Category: Research
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
As Kidney Cancer Awareness Month draws to a close, Scott M. Welford, PhD, the 2014 recipient of the Kure...
Guest Post by Toni Kay Mangskau Mayo Clinic Cancer Center
There has been a series of immunotherapy approvals since the end of last year, and following this trend, on...
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
On Jan. 30, President Obama proposed a $215 million Precision Medicine Initiative, with the goal of revolutionizing medicine. This...
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...